Ilika Q&A: CFO Steve Boydell discusses the £15 million placing in more detail (LON:IKA)

stereax

Ilika plc (LON:IKA) Chief Financial Officer Steve Boydell caught up with DirectorsTalk for an exclusive interview to discuss the placing of £15 million in more detail.

Q1: On Friday, Ilika announced that it had completed a placing of £15 million, what have the funds been raised for?

A1: The funding has been raised to drive the company’s roadmap across its portfolio of solid state battery programmes.

In rough numbers, £4 million has been earmarked to support the transfer of our miniature batteries, branded Stereax, into a third party fabrication facility. A further £4 million provides us with the option to dual-source this production at another fab and the balance is to support our contribution to our larger format battery programme, which we’ve branded Goliath, and enables us to strengthen the balance sheet and provide additional working capital.

Q2: Has the funding been raised mostly from new or existing shareholders?

A2: We’ve received strong support from our existing investor base who have taken approximately 60% of the placing with the balance coming from a small number of new holders, one of whom is a tier 1 investor who will have a disclosable 5% holding in the company once the deal has been completed.

Q3: Ilika has developed quite a retail investor base, will these investors be able to participate?

A3: Yes, so addition to the placing, we have announced an open offer of up to an additional £2 million. This has been done to enable all of our shareholders to participate on the same terms as the institutions as we recognise how important these investors are in supporting the company as we grow the company and commercialise our solid state battery technology.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video)

Ilika plc has crossed a commercial milestone with its first regular revenue stream from its Stereax battery line, according to Dr Tom McColm of Morphose Capital. With strong cash reserves, momentum on its Goliath platform, and growing interest from defence sectors, the next 12 months could be transformational.

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

Ilika CEO Graeme Purdy shares how the company has shifted from commissioning to customer deliveries of its Stereax batteries — and why its Goliath EV programme is designed to beat the commoditised market with faster charging and extended range.

Ilika reports on-track progress across Stereax and Goliath in H1 2025/26

Ilika reports unaudited half-year results to 31 October 2025, highlighting on-schedule delivery of key commercial milestones across its Stereax medical battery and Goliath EV battery programmes, alongside continued customer validation, pilot-line commissioning, and £4.2m fundraising to support its roadmap.

Ilika secures first commercial Stereax electrode order from Cirtec Medical

Ilika has received its first revenue-generating purchase order from Cirtec Medical for the supply of Stereax electrodes, marking the transition of their partnership into commercial production.

Solid state design drives weight, cost and efficiency gains

Solid state design offers Ilika a compelling path to value through weight savings, pack simplification and improved EV performance.

Ilika aligns solid state production with lithium-ion supply chains

Ilika’s Goliath batteries are being scaled with standard lithium-ion tools and low-cost materials to match today’s battery economics.

Search

Search